No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Medical - Devices
Vincent Medical Holdings Limited is an investment holding company engaged in the comprehensive process of designing, manufacturing, marketing, and distributing medical devices. Its operations are bifurcated into two main business models: providing products for other companies (Original Equipment Manufacturing, or OEM) and selling goods under its own proprietary labels (Original Brand Manufacturing). For its OEM clientele, the company specializes in developing respiratory care products, disposable components for imaging contrast media power injectors, and a range of orthopedic and rehabilitation solutions. Its extensive respiratory portfolio encompasses humidification systems, nCPAP interface systems, dedicated respiratory care units, electronic air-oxygen blenders, and anesthesia systems. In the orthopedic and rehabilitation sector, Vincent Medical offers various adjustable braces engineered for post-injury or post-surgical support, protection, and recovery of musculoskeletal areas. The company also pioneers the development of robotic hand training devices. Under its own brand names, including Inspired Medical, Hand of Hope, and Hypnus, Vincent Medical Holdings Limited distributes its offerings across a wide international market. Key regions include the People's Republic of China, the United States, the Netherlands, Australia, and Japan. Established in 1997 and headquartered in Hung Hom, Hong Kong, the company functions as a subsidiary of Vincent Raya International Limited.
www.vincentmedical.comNo one on the platform currently holds 1612.HK.
No tracked institution reports a position in 1612.HK as of their last filing.
No one on the platform has traded 1612.HK yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Consensus does not cover every selected forecast year. Later assumptions are extrapolated from available analyst estimates.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 18.2% | — | — | — | ||
| Rev. Growth % | 16.5% | -4.2% | ||||
| Profit Margin % | 11.2% | 6.6% | 6.9% | |||
| Free Cash Flow Margin % | 5.9% | 6.5% | 4.2% | |||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $1.2B | +18.6% | $0.12 | $0.12–$0.12 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| 1612.HKVincent Medical Holdings Limited | $0.67 | +0.00% | $436M | — |
| 1011.HKChina NT Pharma Group Company Limited | $0.36 | +0.00% | $236M | — |
| 1652.HKFusen Pharmaceutical Company Limited | $0.85 | +6.25% | $628M | — |
| 1942.HKMOG Digitech Holdings Limited | $0.07 | +1.41% | $107M | — |
| 2170.HKSuzhou Basecare Medical Corporation Limited | $1.29 | -0.38% | $354M | — |
| 2289.HKCharmacy Pharmaceutical Co., Ltd. | $5.50 | -0.09% | $593M | — |
| 2297.HKRainmed Medical Limited | $0.16 | +1.27% | $224M | — |
Source: Financial Modeling Prep · peers by sector/industry